Clinical use of a monoclonal antibody to bombesin-like peptide in patients with lung cancer.
Mulshine
J L
JL
National Cancer Institute-Navy Medical Oncology Branch, Bethesda, Maryland 20814.
Avis
I
I
Treston
A M
AM
Mobley
C
C
Kaspryzyk
P
P
Carrasquillo
J A
JA
Larson
S M
SM
Nakanishi
Y
Y
Merchant
B
B
Minna
J D
JD
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000917:Antibody Formation; D001839:Bombesin / Q000276:immunology*; D018288:Carcinoma, Small Cell / Q000276:immunology / Q000628:therapy*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D019886:Gastrin-Releasing Peptide; D006801:Humans; D008175:Lung Neoplasms / Q000276:immunology / Q000628:therapy*; D010455:Peptides / Q000276:immunology*
D000911:Antibodies, Monoclonal; D010455:Peptides; D019886:Gastrin-Releasing Peptide; D001839:Bombesin